374 related articles for article (PubMed ID: 30880280)
1.
Kwak N; Dalcolmo MP; Daley CL; Eather G; Gayoso R; Hasegawa N; Jhun BW; Koh WJ; Namkoong H; Park J; Thomson R; van Ingen J; Zweijpfenning SMH; Yim JJ
Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 30880280
[TBL] [Abstract][Full Text] [Related]
2. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
Kang N; Jeon K; Kim H; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ; Jhun BW
Chest; 2021 Aug; 160(2):436-445. PubMed ID: 33621600
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease.
Im Y; Kim SY; Kim DH; Jhun BW
Chest; 2024 Feb; 165(2):288-302. PubMed ID: 37661004
[TBL] [Abstract][Full Text] [Related]
5.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
6.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
7. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
[TBL] [Abstract][Full Text] [Related]
8. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
Park J; Cho J; Lee CH; Han SK; Yim JJ
Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
Pasipanodya JG; Ogbonna D; Ferro BE; Magombedze G; Srivastava S; Deshpande D; Gumbo T
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807911
[TBL] [Abstract][Full Text] [Related]
10. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
[TBL] [Abstract][Full Text] [Related]
12. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
Nie W; Duan H; Huang H; Lu Y; Chu N
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Portell-Buj E; Bonet-Rossinyol Q; López-Gavín A; Roman A; Fernández-Pittol M; Tudó G; Gonzalez-Martin J
J Antibiot (Tokyo); 2021 Apr; 74(4):285-290. PubMed ID: 33420382
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795
[TBL] [Abstract][Full Text] [Related]
15. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
[TBL] [Abstract][Full Text] [Related]
16. Discrepancies between the genotypes and phenotypes of clarithromycin-resistant
Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
Int J Tuberc Lung Dis; 2018 Apr; 22(4):413-418. PubMed ID: 29562989
[TBL] [Abstract][Full Text] [Related]
17. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
Kim SY; Shin SJ; Jeong BH; Koh WJ
BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
[TBL] [Abstract][Full Text] [Related]
18. Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massiliense.
Oka K; Morioka H; Eguchi M; Sato Y; Tetsuka N; Iguchi M; Kanematsu T; Fukano H; Hoshino Y; Kiyoi H; Yagi T
Intern Med; 2021 Sep; 60(18):3041-3045. PubMed ID: 33775997
[TBL] [Abstract][Full Text] [Related]
19. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
20. Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease.
Park J; Yoon SH; Kim JY; Gu KM; Kwak N; Yim JJ
Respir Med; 2021 Oct; 187():106549. PubMed ID: 34380092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
